![Sui Xiong Cai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 14 M $ al 31/07/2026
Sui Xiong Cai is currently Chief Executive Officer & Executive Director at IMPACT Therapeutics, Inc., a position started in 2025.
Formerly, Dr. Cai was Senior Director-Chemistry at EpiCept Corp.
from 2006 to 2009.
Education includes a doctorate from the University of Oregon, conferred in 1990.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 10/06/2026 | 8.422.233 ( 2,98 % ) | 14 M $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| IMPACT THERAPEUTICS, INC | Director Ejecutivo | 01/06/2014 |
| Empresas | Cargo | Fin |
|---|---|---|
EpiCept Corp.
 EpiCept Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer and pain | Corporate Officer/Principal | 01/01/2009 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
University of Oregon
 University of Oregon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EpiCept Corp.
EpiCept Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer and pain | Health Technology |
IMPACT Therapeutics, Inc.
 IMPACT Therapeutics, Inc. BiotechnologyHealth Technology Operates as a commercial-stage biotechnology company that develops anti-cancer therapies and pharmaceutical products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
